Research News
View articles by month and year
21–30 of 32 articles
-
Expert Panel Votes Against Continuing Approval for Avastin to Treat Metastatic Breast Cancer
A panel of experts voted against continuing the approval of Avastin in combination with Taxol to treat metastatic, HER2-negative breast cancer and also voted unanimously against approving Avastin in combination with other chemotherapy medicines to treat metastatic breast cancer.
-
Avastin Doesn’t Improve Survival in Metastatic Breast Cancer
The FDA is considering whether to continue the approval for using Avastin with Taxol to treat metastatic breast cancer, as well as whether to approve it in combination with other medicines.
-
Adding Avastin to Chemo Stops Metastatic Cancer From Growing
Adding Avastin to any of several common chemotherapy regimens for metastatic, HER2-negative breast cancer seems to lengthen the time before the cancer grows compared to the same regimen without Avastin.
-
Avastin-Abraxane Combo May Treat Triple-Negative Breast Cancer
Research in mice suggests that Avastin combined with Abraxane works better against triple-negative breast cancer cells than Abraxane alone.
-
Avastin Helps Stop Growth of Metastatic Breast Cancer
Research suggests adding Avastin to chemotherapy as the first treatment for metastatic breast cancer increases the length of time before the cancer grows.
-
Avastin Doesn’t Affect Overall Survival in Metastatic Breast Cancer
Two studies suggest that treating metastatic breast cancer with Avastin and chemotherapy slightly increases the length of time women live without the cancer growing, but doesn't affect overall survival.
-
Avastin Ups Blood Clot Risk
New research suggests that Avastin increases the risk of a blood clot in a vein, but the risk varies depending on the type of cancer being treated.
-
Avastin Seems to Offer Benefits in Treating Metastatic Breast Cancer
Women diagnosed with metastatic breast cancer who got Avastin plus Taxotere were less likely to have the cancer progress compared to women who only got Taxotere. Cancers treated with Avastin also were more likely to shrink.
-
Avastin Approved to Treat Breast Cancer
The U.S. Food and Drug Administration has approved Avastin (chemical name: bevacizumab) to treat metastatic breast cancer.
-
Avastin Doesn’t Affect Overall Survival
Avastin combined with Taxol lengthens the time until advanced breast cancer progresses, but doesn't improve overall survival.
21–30 of 32 articles
